Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

12297 from 12311 pages
No results were found for the filter!
Antioxidant agent-3
Antioxidant agent-3

Item number: TGM-T61312-100mg

Description: Antioxidant agent-3 (Compound 14q), a potent antioxidant, exhibits strong scavenging activity against DPPH radicals and ABTS+ radicals with IC50 values of 26.58 µM and 30.31 µM, respectively. Additionally, it enhances levels of reactive oxygen species (ROS), superoxide dismutase (SOD), and glutathione...
MW: 358.3 D
From 1,440.00€ *
Review
HDAC6/HSP90-IN-2
HDAC6/HSP90-IN-2

Item number: TGM-T61315-100mg

Description: HDAC6/HSP90-IN-2 (compound 6e) is a dual inhibitor of HDAC6 and Hsp90 with IC50 values of 105.7 nM and 61 nM, respectively, primarily used in cancer research [1]. Target: Others
MW: 358.39 D
From 1,440.00€ *
Review
CAII-IN-3
CAII-IN-3

Item number: TGM-T61340-100mg

Description: CAII-IN-3 (compound 3h) is a thiosemicarbazone derivative that potently inhibits carbonic anhydrase-II (CA-II), exhibiting an IC50 value of 13.4 µM [1]. Target: Others
MW: 360.42 D
From 1,440.00€ *
Review
Ph-Ph+
Ph-Ph+

Item number: TGM-T61346-100mg

Description: Ph-Ph+ is a hemiprotonic compound derived from the dimerization of phenanthroline (ph), exhibiting notable antitumor, antibacterial, and antifungal properties [1]. Target: Others
MW: 361.42 D
From 1,440.00€ *
Review
D4R antagonist-1
D4R antagonist-1

Item number: TGM-T61347-100mg

Description: D4R Antagonist-1, characterized by its potent and selective antagonistic action against D4 receptors with an IC50 value of 6.87 µM, holds potential for Parkinson's disease research [1]. Target: Others
MW: 361.43 D
From 1,440.00€ *
Review
PqsR-IN-2
PqsR-IN-2

Item number: TGM-T61353-100mg

Description: PqsR-IN-2 (Compound 19) is a highly potent inhibitor of PqsR, the transcriptional regulator of quorum sensing in Pseudomonas aeruginosa. It efficiently suppresses pyocyanin production without significant cytotoxicity, making it a promising candidate for therapeutic applications [1]. Target: Others
MW: 361.89 D
From 1,440.00€ *
Review
CXCR2 antagonist 6
CXCR2 antagonist 6

Item number: TGM-T61359-100mg

Description: CXCR2 antagonist 6 (compound 35c) is a potent CXCR2 antagonist with strong binding affinity (IC50 = 0.044 µM) and effective calcium mobilization (IC50 = 0.66 µM) [1]. Target: Others
MW: 362.4 D
From 1,440.00€ *
Review
NTPDase-IN-1
NTPDase-IN-1

Item number: TGM-T61377-100mg

Description: NTPDase-IN-1 (compound 5a) is a selective inhibitor of NTPDase enzymes with IC50 values of 0.05 µM, 0.23 µM, and 0.54 µM against h-NTPDase-1, h-NTPDase-2, and h-NTPDase-8, respectively. It exerts non-competitive inhibition on h-NTPDase-1 and h-NTPDase-2, with a Km value of 21 µM for h-NTPDase-1. This...
MW: 363.54 D
From 1,440.00€ *
Review
Anticancer agent 29
Anticancer agent 29

Item number: TGM-T61378-100mg

Description: Anticancer agent 29 (Compd E/Z-6f) exhibits potent anticancer activity with IC50 values of 0.054 µM, 0.127 µM, 0.129 µM, and 0.396 µM for CDK2, CDK1, CDK4, and CDK6, respectively [1]. Target: Others
MW: 363.81 D
From 1,440.00€ *
Review
Anticancer agent 30
Anticancer agent 30

Item number: TGM-T61379-100mg

Description: Anticancer agent 30 (compound 6f-Z) is a potent 3-arylidene-2-oxindole derivative that acts as a selective CDK2 inhibitor, showing significant anticancer activity and potential as a cancer treatment [1]. Target: Others
MW: 363.81 D
From 1,440.00€ *
Review
IAA65
IAA65

Item number: TGM-T61393-100mg

Description: IAA65 is a potent inhibitor of T-type calcium channels, exhibiting an IC50 value of 18.9 µM, and holds potential for use in epilepsy research [1]. Target: Others
CAS 2987139-96-6
MW: 365.27 D
From 1,440.00€ *
Review
Anti-inflammatory agent 9
Anti-inflammatory agent 9

Item number: TGM-T61400-100mg

Description: Anti-inflammatory agent 9 (compound 28) is a benzimidazothiazole derivative derived from tilomisole, exhibiting higher COX-2 enzyme affinity than COX-1, thereby demonstrating promising anti-inflammatory properties and oral bioavailability [1]. Target: Others
MW: 365.41 D
From 1,440.00€ *
Review
12297 from 12311 pages